1. Home
  2. NVCR vs AHR Comparison

NVCR vs AHR Comparison

Compare NVCR & AHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • AHR
  • Stock Information
  • Founded
  • NVCR 2000
  • AHR 2013
  • Country
  • NVCR Switzerland
  • AHR United States
  • Employees
  • NVCR N/A
  • AHR N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • AHR
  • Sector
  • NVCR Health Care
  • AHR
  • Exchange
  • NVCR Nasdaq
  • AHR NYSE
  • Market Cap
  • NVCR 1.9B
  • AHR 5.2B
  • IPO Year
  • NVCR 2015
  • AHR 2024
  • Fundamental
  • Price
  • NVCR $17.88
  • AHR $36.37
  • Analyst Decision
  • NVCR Buy
  • AHR Strong Buy
  • Analyst Count
  • NVCR 6
  • AHR 8
  • Target Price
  • NVCR $32.83
  • AHR $37.75
  • AVG Volume (30 Days)
  • NVCR 1.6M
  • AHR 2.0M
  • Earning Date
  • NVCR 07-24-2025
  • AHR 08-07-2025
  • Dividend Yield
  • NVCR N/A
  • AHR 2.75%
  • EPS Growth
  • NVCR N/A
  • AHR N/A
  • EPS
  • NVCR N/A
  • AHR N/A
  • Revenue
  • NVCR $621,711,000.00
  • AHR $2,104,227,000.00
  • Revenue This Year
  • NVCR $5.56
  • AHR $8.10
  • Revenue Next Year
  • NVCR $9.19
  • AHR $6.50
  • P/E Ratio
  • NVCR N/A
  • AHR N/A
  • Revenue Growth
  • NVCR 18.27
  • AHR 10.53
  • 52 Week Low
  • NVCR $14.17
  • AHR $14.79
  • 52 Week High
  • NVCR $34.13
  • AHR $36.96
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 52.95
  • AHR 60.70
  • Support Level
  • NVCR $17.53
  • AHR $35.52
  • Resistance Level
  • NVCR $18.70
  • AHR $36.85
  • Average True Range (ATR)
  • NVCR 0.77
  • AHR 0.93
  • MACD
  • NVCR 0.10
  • AHR -0.04
  • Stochastic Oscillator
  • NVCR 67.33
  • AHR 71.90

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About AHR AMERICAN HEALTHCARE REIT INC

American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.

Share on Social Networks: